Published in Ann Thorac Surg on March 02, 2012
Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med (2002) 22.37
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med (2002) 21.40
A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med (2004) 6.26
Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA (2009) 6.11
Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med (2008) 5.27
Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation (2003) 3.40
Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev (2009) 3.03
Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence. Intensive Care Med (2004) 2.29
Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg (2009) 2.16
The methodologies of hypothermic circulatory arrest and of antegrade and retrograde cerebral perfusion for aortic arch surgery. Ann Thorac Cardiovasc Surg (2008) 1.64
Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation (2010) 1.47
Self-expanding nitinol stents: material and design considerations. Eur Radiol (2003) 1.37
Open and endovascular repair of type B aortic dissection in the Nationwide Inpatient Sample. J Vasc Surg (2010) 1.22
Management of diseases of the descending thoracic aorta in the endovascular era: a Medicare population study. Ann Surg (2010) 1.16
Computational mechanics of Nitinol stent grafts. J Biomech (2008) 1.15
Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation (2011) 1.14
Prophylactic hypothermia for traumatic brain injury: a quantitative systematic review. CJEM (2010) 1.11
Antegrade delivery of stent grafts to treat complex thoracic aortic disease. Ann Thorac Surg (2010) 1.09
Hypothermia for Stroke: call to action 2010. Int J Stroke (2010) 0.92
Resident and fellow experiences after the introduction of endovascular aneurysm repair for abdominal aortic aneurysm. J Vasc Surg (2011) 0.85
Using IVUS during EVAR and TEVAR: improving patient outcomes. Semin Vasc Surg (2009) 0.85
Outcome of elective endovascular abdominal aortic aneurysm repair in octogenarians and nonagenarians. J Vasc Surg (2010) 0.84
Use of systemic hypothermia for patients with spinal cord injury. Neurosurgery (2010) 0.78
Dynamic human cadaver model for testing the feasibility of new endovascular techniques and tools. Ann Vasc Surg (2009) 0.77
A simple technique to facilitate antegrade thoracic endograft deployment using a hybrid elephant trunk procedure under hypothermic circulatory arrest. J Endovasc Ther (2007) 0.77
Histology and electron microscopy of explanted bifurcated endovascular aortic grafts: evidence of early incorporation and healing. J Endovasc Surg (1999) 0.77
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59
An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg (2006) 3.09
Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation (2008) 3.06
Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry. J Vasc Surg (2008) 3.06
Skeletonized internal thoracic artery harvest reduces pain and dysesthesia and improves sternal perfusion after coronary artery bypass surgery: a randomized, double-blind, within-patient comparison. Circulation (2006) 2.54
The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg (2009) 2.32
Endovascular vs open repair for ruptured abdominal aortic aneurysm. J Vasc Surg (2012) 2.23
Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-analysis. Eur J Cardiothorac Surg (2005) 2.19
Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg (2009) 2.16
Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg (2004) 2.13
Effects of alcohol on pericardial adhesion formation in hypercholesterolemic swine. J Thorac Cardiovasc Surg (2012) 2.07
A 69-year-old woman with left main coronary artery disease. JAMA (2004) 2.04
Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg (2006) 2.02
Thirty-day mortality and late survival with reinterventions and readmissions after open and endovascular aortic aneurysm repair in Medicare beneficiaries. J Vasc Surg (2010) 2.02
Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg (2004) 1.96
Patient safety in the cardiac operating room: human factors and teamwork: a scientific statement from the American Heart Association. Circulation (2013) 1.86
Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol (2002) 1.79
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79
Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling. Cell Cycle (2009) 1.77
Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria. J Vasc Surg (2010) 1.73
The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg (2008) 1.68
Population-based outcomes following endovascular and open repair of ruptured abdominal aortic aneurysms. J Endovasc Ther (2009) 1.68
HIV-1 drug resistance surveillance using dried whole blood spots. Antivir Ther (2007) 1.67
High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine. J Thorac Cardiovasc Surg (2006) 1.66
Major lower extremity amputation: outcome of a modern series. Arch Surg (2004) 1.66
Safety and efficacy of a novel gel for vascular occlusion in off-pump surgery. Ann Thorac Surg (2005) 1.61
Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease. Am J Cardiol (2005) 1.60
Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res (2005) 1.60
Accuracy of administrative data versus clinical data to evaluate carotid endarterectomy and carotid stenting. J Vasc Surg (2013) 1.59
Mesenteric revascularization: management and outcomes in the United States, 1988-2006. J Vasc Surg (2009) 1.58
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma. J Clin Oncol (2007) 1.50
Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg (2008) 1.50
Intrapericardial administration of basic fibroblast growth factor: myocardial and tissue distribution and comparison with intracoronary and intravenous administration. Catheter Cardiovasc Interv (2003) 1.49
Characteristics and function of cryopreserved bone marrow-derived endothelial progenitor cells. Ann Thorac Surg (2008) 1.47
Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation (2007) 1.47
Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation (2010) 1.47
Risk prediction for perioperative mortality of endovascular vs open repair of abdominal aortic aneurysms using the Medicare population. J Vasc Surg (2009) 1.46
The impact of endovascular procedures on fellowship training in lower extremity revascularization. J Vasc Surg (2012) 1.44
Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol (2008) 1.41
Postoperative infection associated with polyester patch angioplasty after carotid endarterectomy. J Vasc Surg (2003) 1.39
The peer-review process in medical publishing: a reviewer's perspective. J Thorac Cardiovasc Surg (2003) 1.39
Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation (2010) 1.37
Calcium-activated potassium channels contribute to human coronary microvascular dysfunction after cardioplegic arrest. Circulation (2008) 1.36
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop (2004) 1.34
Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk. J Vasc Surg (2004) 1.34
Population-based outcomes of open descending thoracic aortic aneurysm repair. J Vasc Surg (2008) 1.33
Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.27
Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia. Basic Res Cardiol (2012) 1.26
Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Sci Med Sci (2008) 1.26
Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26
Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res Cardiol (2011) 1.25
Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg (2003) 1.23
Open and endovascular repair of type B aortic dissection in the Nationwide Inpatient Sample. J Vasc Surg (2010) 1.22
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF. Am J Physiol Heart Circ Physiol (2003) 1.21
Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg (2005) 1.18
Calcium-activated potassium channels contribute to human skeletal muscle microvascular endothelial dysfunction related to cardiopulmonary bypass. Surgery (2008) 1.18
Protein kinase C alpha modulates microvascular reactivity in the human coronary and skeletal microcirculation. Surgery (2007) 1.17
Gender differences in abdominal aortic aneurysm presentation, repair, and mortality in the Vascular Study Group of New England. J Vasc Surg (2013) 1.17
Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg (2007) 1.16
Risk of late-onset adhesions and incisional hernia repairs after surgery. J Am Coll Surg (2013) 1.16
Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxid Redox Signal (2009) 1.14
Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle. Arch Surg (2011) 1.14
Differences in gene expression profiles of diabetic and nondiabetic patients undergoing cardiopulmonary bypass and cardioplegic arrest. Circulation (2004) 1.13
Should aortas in patients with bicuspid aortic valve really be resected at an earlier stage than tricuspid? CON. Cardiol Clin (2010) 1.12
Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg (2009) 1.12
Vascular injury during anterior exposure of the spine. J Vasc Surg (2008) 1.12
Cardiopulmonary bypass reduces peripheral microvascular contractile function by inhibition of mitogen-activated protein kinase activity. Surgery (2003) 1.11
C-Reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery. Surgery (2006) 1.11
Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol (2009) 1.11
Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion. Circulation (2009) 1.10
Resveratrol in the prevention and treatment of coronary artery disease. Curr Atheroscler Rep (2011) 1.10
Decreased vascular repair and neovascularization with ageing: mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1. Curr Mol Med (2008) 1.09
Preoperative pulse pressure and major perioperative adverse cardiovascular outcomes after lower extremity vascular bypass surgery. Anesth Analg (2011) 1.09
Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg (2005) 1.08
Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia. Eur J Pharmacol (2011) 1.08
Vacuum assisted vegetation extraction for the management of large lead vegetations. J Card Surg (2013) 1.07
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2006) 1.06
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma. J Clin Oncol (2005) 1.06
Mitogen-activated protein kinase inhibition and cardioplegia-cardiopulmonary bypass reduce coronary myogenic tone. Circulation (2003) 1.06